Paper36958337
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.
Richard J and 18 others. Cell Chem Biol, 2023. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Papers, record 36958337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| CD4-Positive T-Lymphocytes | |
| Down-Regulation | |
| HIV Envelope Protein gp120 | |
| Cytokines |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI148379 | NIAID NIH HHS | United States | R01AI148379 | PubMed and NIH | NIH RePORTER |
| P01 AI150471 | NIAID NIH HHS | United States | P01AI150471 | PubMed and NIH | NIH RePORTER |
| R01 AI129769 | NIAID NIH HHS | United States | R01AI129769 | PubMed and NIH | NIH RePORTER |
| R01 AI150322 | NIAID NIH HHS | United States | R01AI150322 | PubMed and NIH | NIH RePORTER |
| P01 GM056550 | NIGMS NIH HHS | United States | P01GM056550 | PubMed | NIH RePORTER |
| R01AI174908 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07030920 | Reducing Systemic Inflammation in People on Antiretroviral Therapy | Background |
Source ClinicalTrials.gov
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29162799 | Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. | Nat Commun | 2017 | https://conductscience.org/library/papers/29162799 | PubMed |
| 2 | 12951026 | Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits. | Virology | 2003 | https://conductscience.org/library/papers/12951026 | PubMed |
| 3 | 29162391 | Impact of HIV-1 Envelope Conformation on ADCC Responses. | Trends Microbiol | 2018 | https://conductscience.org/library/papers/29162391 | PubMed |
| 4 | 26575148 | Residual inflammation and viral reservoirs: alliance against an HIV cure. | Curr Opin HIV AIDS | 2016 | https://conductscience.org/library/papers/26575148 | PubMed |
| 5 | 25298114 | Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. | Science | 2014 | https://conductscience.org/library/papers/25298114 | PubMed |
| 6 | 9110072 | gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: an immunoelectron microscopic study. | AIDS | 1997 | https://conductscience.org/library/papers/9110072 | PubMed |
| 7 | 24516533 | Slow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivo. | PLoS One | 2014 | https://conductscience.org/library/papers/24516533 | PubMed |
| 8 | 29561264 | HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations. | Elife | 2018 | https://conductscience.org/library/papers/29561264 | PubMed |
| 9 | 23886064 | Residual immune dysregulation syndrome in treated HIV infection. | Adv Immunol | 2013 | https://conductscience.org/library/papers/23886064 | PubMed |
| 10 | 21762802 | HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. | J Mol Biol | 2011 | https://conductscience.org/library/papers/21762802 | PubMed |
| 11 | 29394935 | Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs. | Retrovirology | 2018 | https://conductscience.org/library/papers/29394935 | PubMed |
| 12 | 25174000 | A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry. | Nat Chem Biol | 2014 | https://conductscience.org/library/papers/25174000 | PubMed |
| 13 | 19231994 | HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19231994 | PubMed |
| 14 | 21471235 | Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. | J Virol | 2011 | https://conductscience.org/library/papers/21471235 | PubMed |
| 15 | 32817216 | Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor. | J Virol | 2020 | https://conductscience.org/library/papers/32817216 | PubMed |
| 16 | 28100618 | Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses. | J Virol | 2017 | https://conductscience.org/library/papers/28100618 | PubMed |
| 17 | 24128669 | Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068. | J Antimicrob Chemother | 2014 | https://conductscience.org/library/papers/24128669 | PubMed |
| 18 | 33013157 | Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-Trifluoroacetate Salt. | Org Process Res Dev | 2019 | https://conductscience.org/library/papers/33013157 | PubMed |
| 19 | 18842730 | Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. | J Virol | 2008 | https://conductscience.org/library/papers/18842730 | PubMed |
| 20 | 19698075 | HIV-1 envelope protein gp120 is present at high concentrations in secondary lymphoid organs of individuals with chronic HIV-1 infection. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19698075 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42728469 | Impact of Fostemsavir in Individuals with Multidrug-Resistant HIV-1, Stratified by Baseline Viral Load. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/42728469 | PubMed |
| 42655632 | HIV-1 Env Heterogeneity: Cleavage, Trafficking, and Antigenic Consequences for Virions and Infected Cells. | Viruses | 2026 | https://conductscience.org/library/papers/42655632 | PubMed |
| 42322610 | Comprehensive mapping of the virus and host factors that guide the paths of HIV-1 escape from a therapeutic. | Cell Rep | 2026 | https://conductscience.org/library/papers/42322610 | PubMed |
| 42317333 | Research progress on HIV-1 structural proteins and antiviral therapies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317333 | PubMed |
| 41639021 | Immune non-response despite effective antiretroviral therapy in people living with HIV: A review of potential mechanisms, biomarkers and therapeutic approaches. | HIV Med | 2026 | https://conductscience.org/library/papers/41639021 | PubMed |
| 41600811 | Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill. | Viruses | 2025 | https://conductscience.org/library/papers/41600811 | PubMed |
| 41497656 | Comprehensive Mapping of the Virus and Host Factors that Guide the Paths of HIV-1 Escape from a Therapeutic. | bioRxiv | 2025 | https://conductscience.org/library/papers/41497656 | PubMed |
| 41201241 | Highly efficient production of HIV-1AD8 gp120 in mammalian cells. | J Virol | 2025 | https://conductscience.org/library/papers/41201241 | PubMed |
| 40990223 | Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. | J Infect Dis | 2026 | https://conductscience.org/library/papers/40990223 | PubMed |
| 39868926 | NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders Living With HIV. | J Med Virol | 2025 | https://conductscience.org/library/papers/39868926 | PubMed |
| 39827271 | α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia. | Nat Commun | 2025 | https://conductscience.org/library/papers/39827271 | PubMed |
| 39373535 | CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies. | mBio | 2024 | https://conductscience.org/library/papers/39373535 | PubMed |
| 39339960 | New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs. | Viruses | 2024 | https://conductscience.org/library/papers/39339960 | PubMed |
| 39233711 | Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study. | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/39233711 | PubMed |
| 38756960 | Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach. | JAC Antimicrob Resist | 2024 | https://conductscience.org/library/papers/38756960 | PubMed |
| 38035854 | Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38035854 | PubMed |
| 37957382 | Viral and host mediators of non-suppressible HIV-1 viremia. | Nat Med | 2023 | https://conductscience.org/library/papers/37957382 | PubMed |
| 37954841 | Current drugs for HIV-1: from challenges to potential in HIV/AIDS. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37954841 | PubMed |
| 37243275 | Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage. | Viruses | 2023 | https://conductscience.org/library/papers/37243275 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36958337
GET https://conductscience.org/api/papers/v1/36958337/references?page=2